Novartis AG
XHAM:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
XHAM:NOT
|
CH |
|
V
|
Vinci SA
XMUN:SQU
|
FR |
|
Hummingbird Resources PLC
F:2HM
|
UK |
|
Hindustan Aeronautics Ltd
NSE:HAL
|
IN |
|
T
|
Tele2 AB
XMUN:NCYD
|
SE |
|
W
|
Whitbread PLC
OTC:WTBDY
|
UK |
|
I
|
Invesco Ltd
XMUN:3IW
|
US |
|
DaVita Inc
NYSE:DVA
|
US |
|
L
|
Lam Research Corp
F:LAR
|
US |
|
C
|
CenterPoint Energy Inc
DUS:HOU
|
US |
|
Cintas Corp
NASDAQ:CTAS
|
US |
|
Sumitomo Chemical Co Ltd
OTC:SOMMF
|
JP |
|
Covivio SA
F:F5D0
|
FR |
|
Beeline Holdings Inc
NASDAQ:BLNE
|
US |
|
S
|
Siemens AG
XMUN:SIE
|
DE |
|
U
|
Urban Outfitters Inc
DUS:UOF
|
US |
|
C
|
Credit Suisse Group AG
XHAM:CSX
|
CH |
|
U
|
United Airlines Holdings Inc
XMUN:UAL1
|
US |
|
T
|
Tsakos Energy Navigation Ltd
F:TK41
|
GR |
|
W
|
Wacker Chemie AG
XHAM:WCH
|
DE |
|
S
|
Stepan Co
F:96S
|
US |
|
Critical Metals PLC
OTC:CRTMF
|
UK |
|
Spie SA
F:4SP
|
FR |
|
Alamtri Resources Indonesia Tbk PT
F:A640
|
ID |
Bankruptcy Probability
Novartis AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novartis AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
Novartis AG
SIX:NOVN
|
227.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
963.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novartis AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novartis AG has total debt of 39.1B USD. This includes both short-term (0 USD) and long-term (39.1B USD) debt.
You can find a full breakdown on its Balance Sheet.
